BAY-2666605

N/A

Report date: 2024/06/05 16:42:54
NME

Base Information

Drug NameBAY-2666605
Drug Alias NameBAY-2666605BAY2666605SLFN12 ci
ClassificationSmall molecules > Molecular GlueSmall molecules > Heterocyclic drugs
Mechanisms of ActioncGMP-inhibited 3',5'-cyclic phosphodiesterase A bindersSchlafen family member 12 bindersApoptosis stimulants
TargetscGMP-inhibited 3',5'-cyclic phosphodiesterase ASchlafen family member 12
Therapy Area/IndicationsSolid tumoursMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AGBroad Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsSolid tumoursMelanoma

Other Information

ATC CodeN/A
Related LinksN/A